Shares of Genpact (NYSE: G), a global professional services firm, plummeted 18.22% in intraday trading on Thursday, despite reporting better-than-expected first-quarter earnings. The sharp decline came as the company lowered its full-year guidance and several analysts cut their price targets, raising concerns among investors about the company's future growth prospects.

Genpact reported adjusted earnings of 84 cents per share for Q1 2025, surpassing analysts' expectations of 79 cents per share. Revenue rose 7.4% year-over-year to $1.21 billion, meeting Wall Street's projections. However, the positive earnings report was overshadowed by the company's decision to lower its FY2025 outlook. Genpact slashed its FY2025 GAAP EPS guidance from $3.04-$3.11 to $2.90-$3.01 and adjusted EPS guidance from $3.52-$3.59 to $3.41-$3.52.

Adding to investor concerns, several analysts downgraded their price targets for Genpact following the earnings announcement. JP Morgan cut its target price from $55 to $49, while Needham lowered its target from $55 to $50. Baird maintained a Neutral rating but also reduced its price target from $56 to $50. These downgrades, combined with the lowered guidance, appear to have sparked a significant sell-off, as investors reassess Genpact's valuation and growth potential in light of the changing market conditions and company outlook.